Human Endothelium: Target for Aldosterone

Hypertension

Volumn 43, Issue 5, 2004, Pages 952-956

  Oberleithner, Hans ^a   Ludwig, Thomas ^a   Riethmüller, Christoph ^a   Hillebrand, Uta ^a   Albermann, Lars ^a   Schäfer, Claudia ^a   Shahin, Victor ^a   Schillers, Hermann ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Endothelium; Mineralocorticoids

Indexed keywords

ALDOSTERONE; AMILORIDE; DIURETIC AGENT; MINERALOCORTICOID RECEPTOR; SODIUM CHANNEL BLOCKING AGENT; SPIRONOLACTONE;

ARTICLE; ATOMIC FORCE MICROSCOPY; CARDIOVASCULAR SYSTEM; CELL MEMBRANE TRANSPORT; CELL SWELLING; CELL VOLUME; CONTROLLED STUDY; DRUG EFFECT; DRUG EXPOSURE; ELECTROLYTE BALANCE; FLUID BALANCE; HUMAN; HUMAN CELL; KIDNEY; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; WATER FLOW;

ALDOSTERONE; ALDOSTERONE ANTAGONISTS; AMILORIDE; BIOLOGICAL TRANSPORT; BODY WATER; CELL SIZE; CELLS, CULTURED; DIURETICS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; MICROSCOPY, ATOMIC FORCE; RECEPTORS, MINERALOCORTICOID; SODIUM; SODIUM CHANNELS; SODIUM-HYDROGEN ANTIPORTER; SPIRONOLACTONE; UMBILICAL VEINS;

EID: 2342594657     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000123572.45556.a5     Document Type: Article

References (33)

1. Robert-Nicoud M, Flahaut M, Elalouf JM, Nicod M, Salinas M, Bens M, Doucet A, Wincker P, Artiguenave F, Horisberger JD, Vandewalle A, Rossier BC, Firsov D. Transcriptome of a mouse kidney cortical collecting duct cell line: effects of aldosterone and vasopressin. Proc Natl Acad Sci U S A. 2001;98:2712-2716.
2. Silvestre JS, Robert V, Heymes C, Aupetit-Faisant B, Mouas C, Moalic JM, Swynghedauw B, Delcayre C. Myocardial production of aldosterone and corticosterone in the rat. Physiological regulation. J Biol Chem. 1998;273:4883-4891.
3. Takeda Y, Miyamori I, Yoneda T, Iki K, Hatakeyama H, Blair IA, Hsieh FY, Takeda R. Production of aldosterone in isolated rat blood vessels. Hypertension. 1995;25:170-173.
4. Epstein M. Aldosterone as a mediator of progressive renal disease: pathogenetic and clinical implications. Am J Kidney Dis. 2001;37:677-688.
5. Lijnen P, Petrov V. Induction of cardiac fibrosis by aldosterone. J Mol Cell Cardiol. 2000;32:865-879.
6. Stier CT, Jr., Chander PN, Rocha R. Aldosterone as a mediator in cardiovascular injury. Cardiol Rev. 2002;10:97-107.
7. Palmieri EA, Biondi B, Fazio S. Aldosterone receptor blockade in the management of heart failure. Heart Fail Rev. 2002;7:205-219.
8. Schneider SW, Yano Y, Sumpio BE, Jena BP, Geibel JP, Gekle M, Oberleithner H. Rapid aldosterone-induced cell volume increase of endothelial cells measured by the atomic force microscope. Cell Biol Int. 1997;21:759-768.
9. Lombes M, Oblin ME, Gasc JM, Baulieu EE, Farman N, Bonvalet JP. Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor. Circ Res. 1992;71:503-510.
10. Golestaneh N, Klein C, Valamanesh F, Suarez O, Agarwal MK, Mirshahi M. Mineralocorticoid receptor-mediated signaling regulates the ion gated sodium channel in vascular endothelial cells and requires an intact cytoskeleton. Biochem Biophys Res Commun. 2001;280:1300-1306.
11. Oberleithner H, Schneider SW, Albermann L, Hillebrand U, Ludwig T, Riethmüller C, Shahin V, Schäffer C, Schillers H. Endothelial cell swelling by aldosterone. J Membrane Biol. 2003;196:163-172.
12. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest. 1973;52:2745-2756.
13. Goerge T, Niemeyer A, Rogge P, Ossig R, Oberleithner H, Schneider SW. Secretion pores in human endothelial cells during acute hypoxia. J Membr Biol. 2002;187:203-211.
14. Schneider SW, Matzke R, Radmacher M, Oberleithner H. Shape and volume of living aldosterone-sensitive cells imaged with the atomic force microscope. In: Braga PC, Ricci D, eds. Methods in Molecular Biology. Totowa, NJ: Humana Press; 2003.
15. Garty H. Regulation of the epithelial Na+ channel by aldosterone: open questions and emerging answers. Kidney Int. 2000;57:1270-1276.
16. Frindt G, Masilamani S, Knepper MA, Palmer LG. Activation of epithelial Na channels during short-term Na deprivation. Am J Physiol Renal Physiol. 2001;280:F112-F118.
17. Zhou ZH, Bubien JK. Nongenomic regulation of ENaC by aldosterone. Am J Physiol Cell Physiol. 2001;281:C1118-C1130.
18. Agarwal MK, Mirshahi M. General overview of mineralocorticoid hormone action. Pharmacol Ther. 1999;84:273-326.
19. Besseghir K, Rennick B. Renal tubule transport and electrolyte effects of amiloride in the chicken. J Pharmacol Erp Ther. 1981;219:435-441.
20. Spahn H, Reuter K, Mutschler E, Gerok W, Knauf H. Pharmacokinetics of in renal and hepatic disease. Eur J Clin Pharmacol, 1997;33:493-498.
21. Kretschmar K, Engelhardt T. Swelling of capillary endothelial cells contributes to traumatic hemorrhagic shock-induced microvascular injury: a morphologic and morphometric analysis. Int J Microcirc Clin Exp. 1994;14:45-49.
22. Mazzoni MC, Intaglietta M, Cragoe EJ, Jr., Arfors KE. Amiloride-sensitive Na+ pathways in capillary endothelial cell swelling during hemorrhagic shock. J Appl Physiol. 1992;73:1467-1473.
23. Behmanesh S, Kempski O. Mechanisms of endothelial cell swelling from lactacidosis studied in vitro. Am J Physiol Heart Circ Physiol. 2000;279:H1512-H1517.
24. + exchange and raises cytoplasmic pH in target cells of the amphibian kidney. Proc Natl Acad Sci U S A. 1987;84:1464-1468.
25. + exchange in the control of intracellular pH and cell membrane conductances in frog skin epithelium. J Gen Physiol. 1988;92:793-810.
26. Wehling M, Kuhls S, Armanini D. Volume regulation of human lymphocytes by aldosterone in isotonic media. Am J Physiol. 1989;257(2 Pt 1):E170-E174.
27. 2+ and stimulation of a plasma membrane proton conductance. Proc Natl Acad Sci USA. 1996;93:10500-10504.
28. Young WF, Jr. Minireview: primary aldosteronism-changing concepts in diagnosis and treatment. Endocrinology. 2003;144:2208-2213.
29. Lim PO, Young WF, MacDonald TM. A review of the medical treatment of primary aldosteronism. J Hypertens. 2001;19:353-361.
30. Stowasser M. Primary aldosteronism: revival of a syndrome. J Hypertens. 2001;19:363-366.
31. Giebisch GH. A trail of research on potassium. Kidney Int. 2002;62:1498-1512.
32. Amorim JB, Bailey MA, Musa-Aziz R, Giebisch G, Malnic G. Role of luminal anion and pH in distal tubule potassium secretion. Am J Physiol Renal Physiol. 2003;284:F381-F388.
33. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 2003;348:1309-1321.